Mustang Bio (MBIO) Other Operating Expenses (2016 - 2024)

Mustang Bio (MBIO) posted quarterly Other Operating Expenses of $2.6 million for Q2 2024, up 2203.48% quarter-over-quarter from $115000.0 in Q4 2023.

Mustang Bio (MBIO) Other Operating Expenses (2016 - 2024) Analysis & Trends

Mustang Bio (MBIO) has reported Other Operating Expenses for 9 consecutive years, with $2.6 million the latest figure, recorded in Q2 2024.

In Q2 2024, Other Operating Expenses changed N/A year-over-year to $2.6 million; the TTM figure through Mar 2025 stood at $2.6 million (up 80.7% YoY), while the FY2023 annual figure was $1.5 million, down 0.54% from the prior year.
Other Operating Expenses advanced to $2.6 million in Q2 2024 per MBIO's latest filing, from $115000.0 in the prior quarter.
Across five years, Other Operating Expenses topped out at $8.2 million in Q4 2020 and bottomed at $40000.0 in Q3 2022.
Historically, Other Operating Expenses has averaged $1.8 million across 5 years, with a median of $1.2 million in 2020.
Annual changes were most pronounced in 2022 — Other Operating Expenses plunged 93.65% — and 2023, when it surged 3277.5%.
Mustang Bio's Other Operating Expenses stood at $8.2 million in 2020, then plunged by 48.8% to $4.2 million in 2021, then tumbled by 65.95% to $1.4 million in 2022, then plunged by 91.98% to $115000.0 in 2023, then surged by 2203.48% to $2.6 million in 2024.
Business Quant data shows MBIO's Other Operating Expenses at $2.6 million in Q2 2024, $115000.0 in Q4 2023, and $1.4 million in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Mustang Bio	3.90 Mn	3.90 Mn	-

Download Data